4//SEC Filing
CTI BIOPHARMA CORP 4
Accession 0000891293-16-000094
CIK 0000891293operating
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 5:10 PM ET
Size
12.2 KB
Accession
0000891293-16-000094
Insider Transaction Report
Form 4
Plunkett Matthew
EVP, Corporate Development
Transactions
- Sale
Common Stock
2016-02-04$1.15/sh−5,000$5,750→ 604,684 total - Sale
Common Stock
2016-02-04$1.16/sh−3,000$3,465→ 601,684 total - Sale
Common Stock
2016-02-04$1.17/sh−700$819→ 600,384 total - Sale
Common Stock
2016-02-04$1.14/sh−400$456→ 609,684 total - Sale
Common Stock
2016-02-04$1.16/sh−600$696→ 601,084 total - Sale
Common Stock
2016-02-04$1.18/sh−300$353→ 600,084 total
Footnotes (1)
- [F1]The sale was effected pursuant to a Rule 10b5-1 trading plan.
Documents
Issuer
CTI BIOPHARMA CORP
CIK 0000891293
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000891293
Filing Metadata
- Form type
- 4
- Filed
- Feb 4, 7:00 PM ET
- Accepted
- Feb 5, 5:10 PM ET
- Size
- 12.2 KB